Electronic devices for home use which measure physical health parameters such as blood pressure, heart rate, blood oxygen levels and activity etc. proliferate. Results from them may be shared, usually as a part of a treatment programme, with a doctor, nurse or pharmacist. However, what is not being regularly monitored is the patient’s general health and well-being. IT companies have been encouraged to develop software to allow patients to record and display this at home, using a mobile programme or app – one such is Vinehealth.
It would be good if C-Side members, could evaluate this, since there is no doubt that programmes such as this will become commonplace in the not too distant future.
You can learn more about Vinehealth here (or click on the picture). You can download the app from the App Store (Apple) and Google Play, It is free to download and use and is unlikely to present any risk to confidential information. Remember it is a mobile app, designed for use on a phone (IOS or Android) or an iPad; not at present on a laptop or similar.
This development, at first sight, looks like an April Fool spoof, but it isn’t. The article describes a proceedure where a small camera (with its own light source) is introduced into the digestive sysem orally. During its transit it captures images of the bowel wall in order to reveal abnormalities. Imagery is radio transmitted to a receiver carried by the patient.
Many proceedureds and treatments are now being considered as a way to reduce visits by patients to hospitals, beset as they now are by Covid cases. This is being roled out in Scotland; one wonders why not in the rest of the UK?
Click on the photo to see the complete article published by the BBC in November.
NICE recommends new combination treatment for advanced bowel cancer
Bowel Cancer UK
Friday 20 November 2020
Today the National Institute for Heath and Care Excellence (NICE) announce their final recommendation for a new treatment combination for people diagnosed with a rare form of bowel cancer. NICE draft guidance initially refused to recommend the treatment due to its cost effectiveness.
The drugs – BRAFTOVI® (encorafenib) in combination with Erbitux® (cetuximab) – will be available within three months on the NHS for adults with a particular form of colorectal cancer, known as BRAFV600E mutant metastatic colorectal cancer (mCRC), living in England and Wales.
Researchers found the combination of the two drugs significantly improved the amount of time patients lived after receiving the treatment, with a median overall survival rate (the amount of time patients lived after receiving the treatment) increasing from 5.9 months to 9.3 months compared to other treatments. It also reduced the risk of death by 39%, compared to the control arm of the trial.
In June 2020, the combination took a major step forward when it was approved by the European Commission. However NICE published draft guidance in September not recommending the combination of drugs because of its cost effectiveness, but after reviewing feedback from the clinical community, charities like us, and patients who have been affected by the decision, they are now recommending the drug to be used on the NHS.
Genevieve Edwards, Chief Executive of Bowel Cancer UK, said: “Approximately one in ten people diagnosed with advanced bowel cancer have a BRAFV600E mutation, and their treatment options are currently extremely limited. We worked closely with clinicians to submit evidence to the NICE consultation on the benefits of the combined therapy, and are really pleased that today’s announcement offers new hope to patients.”
Here’s part of a message form Rosie Sadler from the Brighter Outlook Team – Albion in the Community. It followed on from a meeting where attendess were able to share their expert knowledge and tips and advice on living well with and beyond bowel cancer, and/or a stoma, and the effects of treatments.
Here’s some links and contact information for points of contact on what was discussed.
C-Side Support Group
Support group for anyone affected by colorectal cancer. For more information on the C-side support group visit their website http://c-sidebrighton.org/
If you would like to join their next meet up, either on zoom or when it restarts (at the Horizon Centre), contact either:
Denise Savage firstname.lastname@example.org
Or Steve Tedman (Chair of C-Side) Steve.email@example.com
Contact details for Stoma Nurses or Colorectal Nurses if you have any problems or questions, they’re always happy to help J
Background to the Event During the pandemic, Macmillan has discovered from our social media shout-outs in September (Instagram, Twitter and Facebook), that 94% of people want to hear from a case study, 94% want to hear about how to manage side effects, 95% want to hear about emotional support and 91% about rights at work.
It is hoped that this event will connect people with cancer together and highlight some of the support that is available during the pandemic. It will provide an opportunity for people to hear from Macmillan professionals and other people living with cancer on themes around: treatment and care since the pandemic; signposting to Macmillan support; loneliness and isolation; rights at work; and some of the queries that may come up in the live chat.
What’s the Event Format?
Mandy, a person living with cancer, in conversation with Terri (Macmillan communications manager). Broad discussion on themes.
6.30 – 7pm
Presentations from a panel of colleagues across Macmillan, a Clinical Nurse Specialist and the Macmillan Cancer Information Support team. Broad themes will be: treatment and care since the pandemic, and the implications of the pandemic on loneliness and isolation, signposting to Macmillan support, works assessments and rights at work.
During the event, people will be able to submit questions via a live stream.
After the event, the video will still be available to view on Facebook and YouTube and there will be a shareable link to the recording.
Mark Witcomb Macmillan Engagement Lead – Surrey and Sussex Telephone: 07458 056996
Macmillan Cancer Support
3 Fawcett Street, York, YO10 4AH
For information, support or just someone to talk to,
call 0808 808 00 00 or visit macmillan.org.uk
Tailored resources for people with cancer concerned about the coronavirus are available at macmillan.org.uk/coronavirus
Further resources to support Macmillan professionals are available on Learnzone
Cancer care is at a tipping point. During the first wave of the pandemic, thousands of vital appointments, surgeries and treatments were cancelled. Our new report, which launches in the media on Thursday 29 October, reveals the devastating impact this has had for many people living with cancer.
We are extremely concerned to see this happening again in the ‘second wave’, with staff being redeployed and intensive care wards filling up in the worst affected areas.
That’s why we’re asking everyone to get behind the Forgotten ‘C’ campaign, as we call for UK Governments to ring fence cancer services to prevent the backlog from growing. This is the most worrying time in recent history to get a cancer diagnosis. Now more than ever, people living with cancer must be able to get the right treatment and care, with the right support, at the right time.
Take action, and show that you see the forgotten ‘C’
Sign and share our open letter, calling on the decision makers for health in England, Wales, Scotland and Northern Ireland to take urgent, radical action now to ring-fence services and prevent the backlog in cancer care and treatment from growing.
“ Hello all, I’m glad to share a brief update from RSCH. We are all now back in our ‘normal’ jobs after a brief period of redeployment during the acute phase of the Covid pandemic earlier this year.
It has been fabulous to welcome two new team members recently, Leanne Tory is our new junior sister, she is working with the team three days/week. Leanne has a wide range of experience including GI surgery and cancer care. Molly Hughes is our new part time Macmillan Support worker, she will be supporting the team two days/week, she is also currently completing her Masters and has a particularly interest in radiotherapy.
The lower GI Macmillan team is still short staffed due to vacancy and maternity leave. We are re-advertising for a band 6, junior sister/charge nurse role and hope we will be able to appoint at the interview late November. The post holder will work three days a week. We look forward to welcoming Zoe our Support worker back from maternity leave in March next year.
In order to ensure people at home have support the team is working differently and have been focussing support on the helpline, to respond as quickly as possible to enquires and help deal with issues and concerns. Due to the reduced staffing levels we have not been able to run our nurse-led clinics or support consultants in clinic but hope to restart these vital services as soon as we can once the team is fully staffed again.
Some tests both in diagnostic phase and follow up have been delayed by Covid but the teams involved are doing their utmost to get investigations done in a timely manner, if you experience any delays please do not hesitate to contact us or if it is a follow up test, contact Claire Theobald and do feedback to the Patient Advice and Liaison Service team about how the delays have left you feeling (01273 64511 or 01273 64973 or email at firstname.lastname@example.org
The Macmillan Horizon Centre is slowly reintroducing services so it’s worth keeping an eye on the web site every few weeks to make sure you don’t miss out on any services